Liver drug metabolism in patients undergoing open-heart surgery.
The effect of open-heart surgery on the drug metabolism of the liver was investigated in 17 patients by using the rate of antipyrine elimination as an index. A correlation was found between the pre-operative heart size and the antipyrine elimination rate. In patients with a markedly dilated heart, the plasma antipyrine half-life was prolonged and apparent clearance significantly impaired. Immediately postoperatively, antipyrine elimination was impaired in all patients. Later, the drug metabolism improved in patients with atrial septal defect, changed temporarily in patients with aortic valve replacement, and remained unchanged in patients with mitral valve replacement. The results indicate that adaptive changes in drug metabolizing capacity occur in patients undergoing cardiac surgery. The changes are related to the type of lesion corrected, the pre-operative functional capacity of the liver, and the time lapse after surgery.
D000293:Adolescent; D000328:Adult; D000983:Antipyrine / Q000097:blood / Q000378:metabolism; D001021:Aortic Valve / Q000601:surgery*; D002306:Cardiac Volume; D005260:Female; D006207:Half-Life; D006344:Heart Septal Defects, Atrial / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013448:Sulfobromophthalein; D013997:Time Factors
D004364:Pharmaceutical Preparations; D013448:Sulfobromophthalein; D000983:Antipyrine